DCM
Defilade Capital Management Portfolio holdings
AUM
$738M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$738M
AUM Growth
–
Holding
33
Top Buys
| 1 | +$55.6M | |
| 2 | +$51.9M | |
| 3 | +$47.5M | |
| 4 |
ICU Medical
ICUI
|
+$45.6M |
| 5 |
Steris
STE
|
+$34M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pfizer
PFE
$154B
| $54.9M | 7.44% |
+2,203,504
|
|
||
2
AbbVie
ABBV
$404B
| $52M | 7.05% |
+227,669
|
|
||
3
Novartis
NVS
$319B
| $50M | 6.78% |
+362,816
|
|
||
|
4
ICU Medical
ICUI
$3.76B
| $48.6M | 6.59% |
+340,745
|
|
||
5
PACS Group
PACS
$6.21B
| $44M | 5.96% |
+1,145,485
|
|
||
6
Eli Lilly
LLY
$983B
| $34.3M | 4.65% |
+31,950
|
|
||
|
7
Steris
STE
$24.2B
| $34.3M | 4.65% |
+135,307
|
|
||
8
Olema Pharmaceuticals
OLMA
$1.98B
| $30.9M | 4.18% |
+1,234,634
|
|
||
9
Revolution Medicines
RVMD
$20.3B
| $28.9M | 3.92% |
+363,454
|
|
||
10
Biogen
BIIB
$28.6B
| $28.5M | 3.86% |
+161,992
|
|
||
11
Nuvalent
NUVL
$8.15B
| $27.1M | 3.67% |
+269,043
|
|
||
12
Intuitive Surgical
ISRG
$175B
| $25.9M | 3.51% |
+45,662
|
|
||
13
Henry Schein
HSIC
$9.81B
| $24.2M | 3.28% |
+320,422
|
|
||
14
Globus Medical
GMED
$12.3B
| $23.3M | 3.16% |
+267,212
|
|
||
15
Xencor
XNCR
$843M
| $21.7M | 2.94% |
+1,414,755
|
|
||
16
Cogent Biosciences
COGT
$6.36B
| $20.2M | 2.74% |
+568,619
|
|
||
17
Align Technology
ALGN
$13.3B
| $20M | 2.71% |
+128,060
|
|
||
18
Ascendis Pharma
ASND
$14.4B
| $18.3M | 2.48% |
+85,694
|
|
||
19
DexCom
DXCM
$28.1B
| $16.3M | 2.2% |
+244,881
|
|
||
20
Becton Dickinson
BDX
$51.9B
| $15.8M | 2.14% |
+81,207
|
|
||
21
AtriCure
ATRC
$1.55B
| $15.7M | 2.13% |
+397,636
|
|
||
22
LivaNova
LIVN
$3.77B
| $14.9M | 2.01% |
+241,413
|
|
||
23
Alphatec Holdings
ATEC
$2.07B
| $13.2M | 1.79% |
+626,754
|
|
||
24
Denali Therapeutics
DNLI
$3.35B
| $10.8M | 1.47% |
+656,713
|
|
||
25
Glaukos
GKOS
$6.85B
| $10.4M | 1.4% |
+91,703
|
|